Levine Glenn N, Bates Eric R, Blankenship James C, Bailey Steven R, Bittl John A, Cercek Bojan, Chambers Charles E, Ellis Stephen G, Guyton Robert A, Hollenberg Steven M, Khot Umesh N, Lange Richard A, Mauri Laura, Mehran Roxana, Moussa Issam D, Mukherjee Debabrata, Ting Henry H, O'Gara Patrick T, Kushner Frederick G, Ascheim Deborah D, Brindis Ralph G, Casey Donald E, Chung Mina K, de Lemos James A, Diercks Deborah B, Fang James C, Franklin Barry A, Granger Christopher B, Krumholz Harlan M, Linderbaum Jane A, Morrow David A, Newby L Kristin, Ornato Joseph P, Ou Narith, Radford Martha J, Tamis-Holland Jacqueline E, Tommaso Carl L, Tracy Cynthia M, Woo Y Joseph, Zhao David X
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information. ACC/AHA Representative. SCAI Representative. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 2015, after the writing effort was completed. In accordance with ACC/AHA policy, she recused herself from the final voting process. ACP Representative. ACEP Representative. Former Task Force member; current member during the writing effort.
Circulation. 2016 Mar 15;133(11):1135-47. doi: 10.1161/CIR.0000000000000336. Epub 2015 Oct 21.